1

ASSESSMENT OF LEFT VENTRICULAR SYSTOLIC ASSESSMENT OF LEFT VENTRICULAR SYSTOLIC

DYSFUNCTION BY TISSUE DOPPLER IMAGINGDYSFUNCTION BY TISSUE DOPPLER IMAGING

SHOWS EVIDENCE OF SUBCLINICAL SHOWS EVIDENCE OF SUBCLINICAL

CARDIOMYOPATHY EARLY AFTER CARDIOMYOPATHY EARLY AFTER

ATHRACYCLINE THERAPYATHRACYCLINE THERAPY

M. LOTRIONTE1, R. NATALI1, G. PALAZZONI1,

G. BIONDI-ZOCCAI2, G. COMERCI1,

M. SAVINO1, F. LOPERFIDO1

(1) Catholic University, Rome, Italy (marzial76@yahoo.it)

(2) University of Turin, Turin, Italy

2

BACKGROUND

• Anthracycline (ANT) chemotherapy for

breast cancer, while associated with high

response rates, is fraught by risks of

irreversible cardiotoxicity

• Unfortunately, means to detect such

cardiotoxicity early on and at a sublinical

stage are lacking

3

OBJECTIVES

• We aimed to evaluate early and late effects of ANT-chemotherapy in patients with breast cancer using standard and systolic tissue Doppler imaging (TDI) echocardiography

• We appraised changes from baseline to follow-up of TDI-derived LV systolic parameters, and explored whether these TDI-parameters could be used to detect myocardial dysfunction before conventional echocardiographic indexes

4

METHODS

• Consecutive patients undergoing ANT-chemotherapy for breast cancer at our Institution, who were routinely referred for standard echocardiography at baseline and after chemotherapy (usually 6 to 12 months after beginning antineoplastic treatment) were enrolled between May 2004 and September 2006

• Comprehensive transthoracic echocardiography was performed using a commercially available ultrasound system with TDI capabilities (Sonos 5500, Philips Medical System, Italy) with a 3.5 MHz phased-array ultrasound probe, by operators unaware of individual chemotherapy schemes

5

METHODS

• TDI measurements were acquired using a 5-10 mm sample volume placed at the lateral and septal mitral annular margins, and at the lateral annulus of the tricuspid valve in the 4-chamber view

• We measured the TDI peak systolic (Sm), early and late diastolic velocities in the LV lateral and septum wall, as well as in the lateral wall of the right ventricle (RV)

• All images were stored onto magneto-optical disc and were measured offline after the completion of the echocardiogram by a single experienced investigator unaware of individual chemotherapy schemes, and with measurements averaged over 3 cycles

6

METHODS• LVEF was considered abnormal if <50%

• We a priori decided to stratify patients according to the pattern of systolic TDI remodelling from baseline to follow-up as follows:– group 1 (no LV TDI systolic worsening) including patients without any

evidence of significant LV systolic dysfunction at follow-up;

– group 2 (minor LV TDI systolic worsening) including subjects with

evidence of significant LV systolic remodelling at follow-up in only one of

the LV regions (ie either in the basal lateral wall or in the basal septum, but

not in both);

– group 3 (major LV TDI systolic worsening) including those with evidence

of significant LV systolic remodelling at follow-up in both the LV lateral wall

and the septum

7

RESULTS

• We enrolled a total of 56 patients (55 females), and

followed them all for 8.8±5.7 months (range 6-24)

• All patients but one with atrial fibrillation had normal sinus

rhythm (80±18) at the time of the ultrasound examination

• Notably, no patient had abnormal LVEF or evidence of

significant LV TDI systolic dysfunction at baseline

• Stratification according to pattern of LV TDI systolic

remodelling allocated 29 (51.8%) patients to group 1, 17

(30.4%) to group 2, and 10 (17.9%) to group 3

8

RESULTS

• No significant increase in major or minor bleedings

(respectively p=0.55 and p=0.98) was found in patients

treated with a high clopidogrel dose

• Sensitivity analysis restricted to randomized trials

confirmed the superiority of a high loading dose regimen

on risk of death or infarction (p=0.001)

• Meta-regression disclosed a significant interaction

between event rate and benefits of high loading dose

(p=0.005), suggesting that the higher the underlying risk,

the greater the favorable impact of high loading

9

PATIENT CHARACTERISTICS

10

CHANGES IN ECHOGRAPHIC DATA AT FOLLOW-UP

11

CHANGES IN TDI DATA AT FOLLOW-UP

12

CHANGES IN END-DIASTOLIC DIAMETER AT FOLLOW-UP

13

CHANGES IN END-SYSTOLIC DIAMETER AT FOLLOW-UP

14

CHANGES IN TELEDIASTOLIC DIAMETER AT FOLLOW-UP

15

CONCLUSIONS

• Subclinical systolic dysfunction occurs in almost 50% of patients early after chemotherapy for breast cancer

• A more adverse by LV-TDI remodelling implies a more pronounced deterioration of standard echocardiographic parameters

• TDI monitoring could thus be envisaged to identify at an earlier stage post-chemotherapy cardiomyopathy, in order to tailor management strategies

For further slides on these topics For further slides on these topics please feel free to visit the please feel free to visit the

metcardio.org website:metcardio.org website:

http://www.http://www.metcardiometcardio..orgorg//slidesslides..htmlhtml